Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

23 Jun, 2017, 09:00 ET Clarivate Analytics ogłasza przełomowe partnerstwo z Impactstory: treści o otwartym dostępie będą łatwiejsze w użyciu dla badaczy

Nowatorskie partnerstwo publiczno-prywatne łączy badaczy ze zweryfikowanymi wersjami około 18 milionów nowych artykułów o otwartym dostępie z Web...


23 Jun, 2017, 09:00 ET Spoločnosť Clarivate Analytics oznamuje historické partnerstvo s firmou Impactstory s cieľom zjednodušiť prístup k voľnému obsahu pre užívateľov

Nové verejno-súkromné partnerstvo umožňuje výskumníkom prístup k overeným verziám približne 18 miliónov nových voľne dostupných článkov na Web of...


23 Jun, 2017, 09:00 ET Clarivate Analytics сообщила о подписании знакового соглашения с Impactstory для упрощения пользования контентом в открытом доступе

Беспрецедентное государственно-частное партнёрство предоставляет исследователям возможность работать с 18 млн. статей, находящихся в открытом...


23 Jun, 2017, 09:00 ET Clarivate Analytics gibt wegweisende Partnerschaft mit Impactstory bekannt, die frei verfügbare Inhalte für Forscher leichter nutzbar machen soll

Neuartige Public-Private-Partnership verschafft Forschern Zugang zu den verifizierten Versionen von geschätzt 18 Millionen neuen, frei verfügbaren...


23 Jun, 2017, 08:47 ET AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the European Committee for Medicinal Products for Human Use (CHMP) of...


23 Jun, 2017, 08:00 ET Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director

Eton Pharmaceuticals, Inc., a development stage pharmaceutical company, today announced the hiring of Sean Brynjelsen as its Chief Executive...


23 Jun, 2017, 08:00 ET MYM Nutraceuticals Acquires CBD Brand 'Joshua Tree'

MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF), is extremely pleased to announce that it has acquired the brand 'Joshua Tree', which includes the...


23 Jun, 2017, 08:00 ET Research and Markets - Biopharmaceutical Contract Manufacturing Market (2017-2027) - Characterized By a Number of Blockbuster Therapies (HUMIRA®, RITUXAN®, Lantus®, Avastin®, Herceptin® and REMICADE®

Research and Markets has announced the addition of the "Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027" report to their...


23 Jun, 2017, 07:58 ET EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for the First-Line Treatment of Advanced Renal Cell Carcinoma in Europe

EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the European...


23 Jun, 2017, 05:00 ET Grifols añade a su cartera de productos moleculares el test de diagnóstico ID RHD XT

- Grifols recibe la autorización de marcado CE para el ID RHD XT - Al detectar las variantes más relevantes del gen RHD, este test de diagnóstico...


23 Jun, 2017, 05:00 ET Grifols aggiunge il kit diagnostico ID RHD XT al suo portafoglio molecolare

- Grifols ha ricevuto l'approvazione del marchio CE per ID RHD XT - Il kit diagnostico individua le varianti più rilevanti del RHD permettendo...


23 Jun, 2017, 05:00 ET Grifols ergänzt sein Molekular-Portfolio mit ID RHD XT Diagnostik-Kit

- Grifols erhält CE-Kennzeichnung für ID RHD XT - Das Diagnostik-Kit erkennt die wichtigsten RHD-Varianten und ermöglicht eine rationellere...


23 Jun, 2017, 05:00 ET Grifols ajoute le kit de diagnostic ID RHD XT à son portefeuille moléculaire

- Grifols reçoit la marque d'homologation CE pour l'ID RHD XT - Le kit de diagnostic détecte les variantes RHD les plus pertinentes, permettant...


23 Jun, 2017, 02:41 ET Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL

Novartis today announced updated results from the ELIANA clinical trial demonstrating CTL019 (tisagenlecleucel) remission rates are maintained at...


23 Jun, 2017, 02:30 ET European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing

Sickle Cell Disease and Beta-thalassemia are two severe diseases that are caused by defects in the beta-globin protein in hemoglobin, present in...


23 Jun, 2017, 02:30 ET European Hematology Association: Shedding New Light on the Prevention of Platelet Storage Lesion

Hemorrhagic and thrombocytopenic patients require platelet transfusion to prevent or treat bleeding. Cold storage of platelets results in complex...


23 Jun, 2017, 02:30 ET European Hematology Association: Delayed Exposure to Common Infections Causes Acute Leukemia of Childhood

Acute leukemia is the most common cancer in childhood and the incidence is increasing especially in socio economic advanced countries. Infection...


23 Jun, 2017, 02:30 ET European Hematology Association: Two is better than one: The Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Rapid Tumor Responses in a Phase 2 Study for Relapsed/Refractory NHL

Cerdulatinib is an oral, dual Syk-JAK inhibitor with a unique mechanism of action. It inhibits two key signaling pathways that promote cancer...


23 Jun, 2017, 02:30 ET European Hematology Association: The More the T-lymphocytes Differ, the More Effectively They Fight Against Leukemia

Adult patients with relapsed or refractory B-cell acute lymphoblastic leukaemia (r/r ALL) have a poor prognosis despite intense salvage...


23 Jun, 2017, 02:30 ET L'association européenne d'hématologie-European Hematology Association : soigner la maladie drépanocytaire et la bêta-thalassémie avec l'édition génomique CRISPR/Cas9

La maladie drépanocytaire et la bêta-thalassémie sont deux maladies graves provoquées par des déficits de la protéine de globine bêta dans...


23 Jun, 2017, 02:30 ET European Hematology Association: La exposición retrasada a las infecciones comunes causa leucemia aguda en la infancia

La leucemia aguda es el tipo de cáncer más común en la infancia, y su incidencia está aumentando, sobre todo en los países socio-económicamente...


23 Jun, 2017, 02:30 ET Association européenne d'hématologie : plus les lymphocytes T sont différents, plus efficacement ils luttent contre la leucémie

Les patients adultes souffrant de leucémie lymphoblastique aigüe à cellules B récidivante ou réfractaire (ALL r/r) ont un pronostic médiocre en...


23 Jun, 2017, 02:30 ET Association européenne d'hématologie : une exposition retardée aux infections communes provoque la leucémie infantile aigüe

La leucémie aigüe est le cancer le plus fréquent chez l'enfant et l'incidence augmente, surtout dans les pays avancés sur le plan...


23 Jun, 2017, 02:30 ET Association européenne d'hématologie : deux valent mieux qu'un : le double inhibiteur SYK / JAK cerdulatinib démontre des réponses rapides aux tumeurs dans une étude de phase II portant sur le lymphome non hodgkinien récidivant / réfractaire

Le cerdulatinib est un inhibiteur double et oral Syk-JAK qui présente un seul mécanisme d'action. Il inhibe deux voies de signalisation clés qui...


23 Jun, 2017, 02:30 ET European Hematology Association: Cuanto más difieren los linfocitos T, mejor luchan contra la leucemia

Los pacientes adultos con leucemia linfoblástica aguda de célula B refractario o en recaída (r/r ALL) tienen un pronóstico pobre a pesar de los...